Evidence map›Paper›PMID 38632569›Full record

ArticleJournal of neuroinflammation2024

Complement propagates visual system pathology following traumatic brain injury.

Davis M Borucki, Baerbel Rohrer, Stephen Tomlinson

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Davis M BoruckiDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
Baerbel RohrerDepartment of Ophthalmology, Medical University of South Carolina, Charleston, SC, USA. rohrer@musc.edu.
Stephen TomlinsonDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA. tomlinss@musc.edu.
Ralph H. Johnson VA Medical Center · USMedical University of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
The Role of Early Life Stress in Feeding BehaviorsP20GM148302 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jose H Ledo · 2023 to 2026
$11.5M
Sex and Gender Supplement to Elastase and Elastin Peptide Activity in Age-Related Macular DegenerationR01EY030072 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ROHRER, BAERBEL · 2020 to 2024
$1.9M
The role of complement in chronic neuroinflammation and cognitive decline after closed head brain injuryI01RX003958 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2023 to 2025
–
The complement system in ALSI21BX005853 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2023 to 2024
–
RPE Cell Bystander Effects Contribute to AMD PathologyI01BX003050 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI ROHRER, BAERBEL · 2016 to 2024
–
BLR&D Research Career Scientist Award Application for Dr. Stephen TomlinsonIK6BX005235 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2020 to 2024
–
BLR&D Research Career Scientist Award for Dr. Barbel RohrerIK6BX004858 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI Baerbel Rohrer · 2020 to 2026
–
Role of complement in TBII01BX004256 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI Stephen Tomlinson · 2019 to 2026
–
Complement Factor H Haplotypes and Smoking in Age-Related Macular DegenerationI01RX000444 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI Baerbel Rohrer · 2011 to 2026
–
BLRD VA I01 BX003050BLRD VA I01 BX004256BLRD VA I21 BX005853BLRD VA IK6 BX004858BLRD VA IK6 BX005235NCI NIH HHS P30 CA138313NEI NIH HHS R01 EY030072NIGMS NIH HHS P20 GM148302NIH HHS P20GM148302NIH HHS P30CA138313NIH HHS R01EY030072RRD VA I01 RX000444RRD VA I01 RX003958
6 · The paper itself

Abstract

backgroundTraumatic brain injury (TBI) is associated with the development of visual system disorders. Visual deficits can present with delay and worsen over time, and may be associated with an ongoing neuroinflammatory response that is known to occur after TBI. Complement system activation is strongly associated with the neuroinflammatory response after TBI, but whether it contributes to vision loss after TBI is unexplored.

methodsAcute and chronic neuroinflammatory changes within the dorsal lateral geniculate nucleus (dLGN) and retina were investigated subsequent to a moderate to severe murine unilateral controlled cortical impact. Neuroinflammatory and histopathological outcomes were interpreted in the context of behavioral and visual function data. To investigate the role of complement, cohorts were treated after TBI with the complement inhibitor, CR2-Crry.

resultsAt 3 days after TBI, complement component C3 was deposited on retinogeniculate synapses in the dLGN both ipsilateral and contralateral to the lesion, which was reduced in CR2-Crry treated animals. This was associated with microglia morphological changes in both the ipsilateral and contralateral dLGN, with a less ramified phenotype in vehicle compared to CR2-Crry treated animals. Microglia in vehicle treated animals also had a greater internalized VGlut2 + synaptic volume after TBI compared to CR2-Crry treated animals. Microglia morphological changes seen acutely persisted for at least 49 days after injury. Complement inhibition also reduced microglial synaptic internalization in the contralateral dLGN and increased the association between VGLUT2 and PSD95 puncta, indicating preservation of intact synapses. Unexpectedly, there were no changes in the thickness of the inner retina, retinal nerve fiber layer or retinal ganglion layer. Neuropathological changes in the dLGN were accompanied by reduced visual acuity at subacute and chronic time points after TBI, with improvement seen in CR2-Crry treated animals.

conclusionTBI induces complement activation within the dLGN and promotes microglial activation and synaptic internalization. Complement inhibition after TBI in a clinically relevant paradigm reduces complement activation, maintains a more surveillance-like microglia phenotype, and preserves synaptic density within the dLGN. Together, the data indicate that complement plays a key role in the development of visual deficits after TBI via complement-dependent microglial phagocytosis of synapses within the dLGN.

Indexed as

Brain Injuries, TraumaticAnimalsComplement ActivationComplement C3InflammationMiceRecombinant Fusion ProteinsRetinal Ganglion CellsComplement C3CR2-Crry fusion protein, mouseRecombinant Fusion Proteins

Identifiers

PMID38632569
PMCPMC11022420
OpenAlexW4394883677

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.